Rankings
▼
Calendar
ELAN Q2 2017 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
Q2 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$719M
Gross Profit
$376M
52.3% margin
Operating Income
$63M
8.7% margin
Net Income
-$64M
-8.9% margin
EPS (Diluted)
$-0.18
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
$45M
Free Cash Flow
$40M
Stock-Based Comp.
$6M
← FY 2017
All Quarters
Q3 2017 →
